Southwest Oncology Group S0802: A Randomized, Phase II Trial of Weekly Topotecan With and Without Ziv-Aflibercept in Patients With Platinum-Treated Small-Cell Lung Cancer

Overview of attention for article published in Journal of Clinical Oncology, July 2014

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (85th percentile)
Above-average Attention Score compared to outputs of the same age and source (62nd percentile)

So far, Altmetric has seen 2 X posts from 2 X users, with an upper bound of 43,682 followers.

SWOG: A Randomized, Phase II Trial of Weekly Topotecan +/- Ziv-Aflibercept in Patients With Platinum-Treated SCLC http://t.co/etfdca4k5C

Ziv-aflibercept improved 3-month PFS in patients with platinum-refractory SCLC, but its addition increased toxicity http://t.co/eESdg5f2TS

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity.